[1] Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome:recommendations of the strategic national stockpile radiation working group. Ann Intern Med, 2004, 140(12):1037-1051.
[2] Dainiak N, Waselenko JK, Armitage JO, et al. The hematologist and radiation casualties. Hematol Am Soc Hematal Educ Program,2003. 473-496.
[3] Liu YJ, Lu SH, Xu B, et al. Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood, 2004, 103(12):4449-4456.
[4] Herodin F, Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol, 2005, 33(10):1071-1080.
[5] DorrW, Noack R, Spekl K, et al. Modification of oral mucositits by keratinocyte growth factor:, single radiation exposure. Int J Radiat Biol, 2001, 77(3):341-347.
[6] Singh VK, Yadav VS. Role of cytokines and growth factors in radioprotection. Exp Mol Pathol, 2005, 78(2):156-169.
[7] Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol, 2002, 30(6):513-528.
[8] Drouet M, Mathieu J, Grenier N, et al. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, Flt-3 Ligand, TPO and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells, 1999, 17(5):273-285.
[9] Min D, Taylor PA, Panoskaltsis-Mortari A, et al. Protection from thymic epithelial cell injury by keratinocyte growth factor:a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood, 2002, 99(12):4592-4600.
[10] 罗庆良, 柳晓兰, 郝静, 等.大剂量全身照射比格狗生物效应观察.军事医学科学院院刊,2002,26(1):14.
[11] Drouet M, Mourcin F, Grenier N, et al. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression:logterm follow-up of hematopoiesis. Blood, 2004, 103(3):878-885.
[12] 罗庆良, 从玉文, 郝静, 等.造血因子与急性放射病.解放军医学杂志,2005,30(3):186-190.
[13] Farese AM, Hunt P, Grab LB, et al. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia. J Clin Invest, 1996, 97(9):2145-2151.
[14] Mason KA, Komaki R, Cox JD, et al. Biology-based combined-modality radiotherapy:workshop report. Int J Radiat Oncol Biol Phys, 2001, 50(4):1079-1089.
[15] Van der MeerenA, Mouthon MA, Gaugler MH, et al. Administration of recombinant human interleukin-11 after supralethal radiation exposure promotes survival in mice:interactive effect with thrombopoietin. Radiat Res, 2002, 157(6):642-649.